Citurgia Biochemicals Ltd Financials
Company Logo

Citurgia Biochemicals Ltd Financial Statement

Citurgia Biochemicals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
RevenueTBA
Operating Expense0.06
Net Profit-0.12
Net Profit MarginTBA
Earning Per Share0.01
EBIDTA-0.06
Effective Tax RateTBA

Citurgia Biochemicals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue AnnualTBA
Operating Expenses Annual0.25
Operating Profit Annual-0.25
Interest Annual0.00
Depreciation0.23
Net Profit Annual-0.48
Tax AnnualTBA

Citurgia Biochemicals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.08
Cash Flow from Operations-0.14
Cash Flow from Investing-0.05
Cash Flow from Financing0.22
Cash Flow at the End0.10

Citurgia Biochemicals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Citurgia Biochemicals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.85
Total Current Assets Annual8.30
Non Current Assets Annual2.74
Total Shareholders Funds Annual-6.57
Total Assets Annual11.04

Citurgia Biochemicals Ltd Earning Calls

No Data Availabe

FAQS on Citurgia Biochemicals Ltd Financials

As of Jun 21, 2025, Citurgia Biochemicals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Citurgia Biochemicals Ltd is with a debt-to-equity ratio of -0.98.

In FY 2024 , Citurgia Biochemicals Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Citurgia Biochemicals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..

Citurgia Biochemicals Ltd's current PE ratio is .

Citurgia Biochemicals Ltd's ROCE averaged 271.5% from the FY ending March 2023 to 2025, with a median of -75.7%. It peaked at 1039.6% in March 2025, reflecting strong capital efficiency over the period..

Citurgia Biochemicals Ltd's latest EBIT is Rs. -0.42 Cr, surpassing the average EBIT of Rs. -0.45 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions